{"id":"W2024644107","doi":"10.1002/art.22025","title":"Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks","year":2006,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1640,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Internal medicine; Placebo; Rheumatology; Rheumatism; Randomized controlled trial; Clinical endpoint; Population; Surgery; Physical therapy; Lymphoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00582877,0.001742725,0.003726622,0.0004842143,0.0006778399,0.001052789,0.001081802,0.002559356,0.003627013],"category_scores_gemma":[0.003244785,0.0007801972,0.001617685,0.000484034,0.001458651,0.001105028,0.0003328206,0.002105279,0.0008660086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000693237,"about_ca_system_score_gemma":0.001427913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004514689,"about_ca_topic_score_gemma":0.0009874696,"domain_scores_codex":[0.9979824,0.001325285,0.0001438638,0.0002455487,0.0001495617,0.0001534033],"domain_scores_gemma":[0.9976805,0.0006185868,0.0006106663,0.0001794162,0.0002076338,0.0007030559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9743303,0.007937238,0.0006449895,0.0004940031,0.001099722,0.00003295841,0.00004128832,0.0001930939,0.00352474,0.00004649003,0.0005016321,0.01115351],"study_design_scores_gemma":[0.95877,0.03913003,0.00101843,0.00001893709,0.0003061154,0.00001862267,0.000005164853,0.000123442,0.000274376,0.00002531053,0.0003028352,0.00000675271],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771107,0.0128615,0.001161116,0.0008508887,0.000583788,0.004963528,0.000904984,0.0001644406,0.001398922],"genre_scores_gemma":[0.9755093,0.006374938,0.003167927,0.00162197,0.00118982,0.008597561,0.001439586,0.00004347612,0.002055344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00582877,"threshold_uncertainty_score":0.03082585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0311017115630682,"score_gpt":0.3213398643868879,"score_spread":0.2902381528238197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}